Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial

Luigi Celio; Sergio Frustaci; Angela Denaro; Angela Buonadonna; Antonio Ardizzoia; Elena Piazza; Alessandra Fabi; Alba Maria Capobianco; Luciano Isa; Luigi Cavanna

首页> 外文期刊>Supportive Care in Cancer >Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial

【24h】

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial

机译：帕洛诺司琼联合1天和3天地塞米松联合预防中度致呕吐化疗后的恶心和呕吐：一项随机，多中心，III期试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Purpose A phase III trial assessed the efficacy of palonosetron plus dexamethasone given once in preventing acute and delayed chemotherapy-induced nausea and vomiting (CINV) following a broad range of moderately emetogenic chemotherapy (MEC) regimens.

机译：目的一项III期临床试验评估了帕洛诺司琼联合地塞米松一次预防的效果，该药在广泛的中度致呕性化疗（MEC）方案后预防急性和延迟化疗引起的恶心和呕吐（CINV）。

著录项

来源
《Supportive Care in Cancer》 |2011年第8期|p.1217-1225|共9页
作者
Luigi Celio; Sergio Frustaci; Angela Denaro; Angela Buonadonna; Antonio Ardizzoia; Elena Piazza; Alessandra Fabi; Alba Maria Capobianco; Luciano Isa; Luigi Cavanna;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献

1. Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial. [J] . Celio L, Frustaci S, Denaro A, Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2011,第8期

机译：帕洛诺司琼联合1天和3天地塞米松联合预防中度致癌的化疗后出现的恶心和呕吐：一项随机，多中心，III期试验。
2. Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following paclitaxel and carboplatin in patients with gynecologic cancers: A randomized, multicenter, phase-II trial [J] . Matsuura Motoki, Satohisa Seiro, Teramoto Mizue, The journal of obstetrics and gynaecology research . 2015,第10期

机译：帕洛诺司琼联合1天和3天地塞米松联合预防紫杉醇和卡铂引起的恶心和呕吐对妇科癌症患者的影响：一项随机，多中心，II期试验
3. Palonosetron Plus 1-Day Dexamethasone for the Prevention of Nausea and Vomiting Due to Moderately Emetogenic Chemotherapy: Effect of Established Risk Factors on Treatment Outcome in a Phase III Trial [J] . CelioL., DenaroA., AgustoniF., The journal of supportive oncology. . 2012,第2期

机译：帕洛诺司琼加1天地塞米松预防中度致呕性化疗引起的恶心和呕吐：已建立的危险因素对III期试验治疗结果的影响
4. Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized multicenter phase III trial [O] . Luigi Celio, Sergio Frustaci, Angela Denaro, -1

机译：帕洛诺司琼联合1天和3天地塞米松联合预防中度致呕吐化疗后的恶心和呕吐：一项随机多中心III期试验
5. Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial [O] . Luigi Celio, null null, Sergio Frustaci, 2010

机译：帕洛诺司琼联合1天和3天地塞米松联合预防中度致呕吐化疗后的恶心和呕吐：一项随机，多中心，III期试验

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅